Bruush Oral Care Inc.
BRSH · NASDAQ
4/30/2023 | 12/31/2022 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.00 | -0.00 | 0.77 |
| FCF Yield | -80.95% | -46.49% | -98.36% | -0.15% |
| EV / EBITDA | -3.77 | -1.59 | -1.51 | -364.63 |
| Quality | ||||
| ROIC | 56.62% | 504.51% | -3,031.06% | 22.15% |
| Gross Margin | 75.63% | 58.31% | 66.25% | 77.17% |
| Cash Conversion Ratio | 5.00 | 0.85 | 13.96 | 0.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 88.41% | 130.00% | 136.13% | 142.75% |
| Free Cash Flow Growth | 0.00% | 72.84% | -1,677.08% | 70.75% |
| Safety | ||||
| Net Debt / EBITDA | -1.72 | -0.03 | 0.01 | -4.90 |
| Interest Coverage | -6.50 | -3.40 | 0.00 | -2.94 |
| Efficiency | ||||
| Inventory Turnover | 0.55 | 4.84 | 1.10 | 0.47 |
| Cash Conversion Cycle | -1,680.23 | -487.50 | -205.60 | -1,120.54 |